These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 32645137)

  • 1. Plasma levels of growth differentiation factor 15 are associated with future risk of venous thromboembolism.
    Hansen ES; Hindberg K; Latysheva N; Aukrust P; Ueland T; Hansen JB; Brækkan SK; Morelli VM;
    Blood; 2020 Oct; 136(16):1863-1870. PubMed ID: 32645137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of von Willebrand factor and future risk of incident venous thromboembolism.
    Edvardsen MS; Hindberg K; Hansen ES; Morelli VM; Ueland T; Aukrust P; Brækkan SK; Evensen LH; Hansen JB
    Blood Adv; 2021 Jan; 5(1):224-232. PubMed ID: 33570640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of mannose-binding lectin and future risk of venous thromboembolism.
    Liang RA; Høiland II; Ueland T; Aukrust P; Snir O; Hindberg K; Braekkan SK; Garred P; Mollnes TE; Hansen JB
    J Thromb Haemost; 2019 Oct; 17(10):1661-1669. PubMed ID: 31220397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated plasma D-dimer levels are associated with risk of future incident venous thromboembolism.
    Hansen ES; Rinde FB; Edvardsen MS; Hindberg K; Latysheva N; Aukrust P; Ueland T; Michelsen AE; Hansen JB; Brækkan SK; Morelli VM
    Thromb Res; 2021 Dec; 208():121-126. PubMed ID: 34763296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement activation assessed by the plasma terminal complement complex and future risk of venous thromboembolism.
    Høiland II; Liang RA; Braekkan SK; Pettersen K; Ludviksen JK; Latysheva N; Snir O; Ueland T; Hindberg K; Mollnes TE; Hansen JB
    J Thromb Haemost; 2019 Jun; 17(6):934-943. PubMed ID: 30920726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genetic effects of hormones modulated by the Pituitary-Thyroid/Adrenal/Gonadal axis on the risk of developing venous thromboembolism: a mendelian randomization study.
    Tian H; Xie C; Teng B; Zeng Q; Zhao Y; Li F; Jiang C; Chen Z
    BMC Cardiovasc Disord; 2024 Jul; 24(1):383. PubMed ID: 39054435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated plasma levels of plasminogen activator inhibitor-1 are associated with risk of future incident venous thromboembolism.
    Frischmuth T; Hindberg K; Aukrust P; Ueland T; Braekkan SK; Hansen JB; Morelli VM
    J Thromb Haemost; 2022 Jul; 20(7):1618-1626. PubMed ID: 35289062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of growth differentiation factor 15 on the risk of cardiovascular diseases: two-sample Mendelian randomization study.
    Wang Z; Yang F; Ma M; Bao Q; Shen J; Ye F; Xie X
    BMC Cardiovasc Disord; 2020 Oct; 20(1):462. PubMed ID: 33115406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of platelet-derived microvesicles are associated with risk of future venous thromboembolism.
    Snir O; Wilsgård L; Latysheva N; Wahlund CJE; Braekkan SK; Hindberg K; Hansen JB
    J Thromb Haemost; 2022 Apr; 20(4):899-908. PubMed ID: 35000275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Levels of Complement Activating Enzyme MASP-2 Are Associated With the Risk of Future Incident Venous Thromboembolism.
    Damoah CE; Snir O; Hindberg K; Garred P; Ludviksen JK; Brækkan SK; Morelli VM; Mollnes TE; Hansen JB;
    Arterioscler Thromb Vasc Biol; 2022 Sep; 42(9):1186-1197. PubMed ID: 35861070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of P-selectin and future risk of incident venous thromboembolism.
    Swamy S; Ueland T; Hansen JB; Snir O; Brækkan SK
    J Thromb Haemost; 2023 Sep; 21(9):2451-2460. PubMed ID: 37182696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the von Willebrand factor-ADAMTS-13 axis on the risk of future venous thromboembolism.
    Edvardsen MS; Hansen ES; Ueland T; Aukrust P; Brækkan SK; Morelli VM; Hansen JB
    J Thromb Haemost; 2023 May; 21(5):1227-1237. PubMed ID: 36736832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taller height as a risk factor for venous thromboembolism: a Mendelian randomization meta-analysis.
    Roetker NS; Armasu SM; Pankow JS; Lutsey PL; Tang W; Rosenberg MA; Palmer TM; MacLehose RF; Heckbert SR; Cushman M; de Andrade M; Folsom AR
    J Thromb Haemost; 2017 Jul; 15(7):1334-1343. PubMed ID: 28445597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Levels of Leptin and Risk of Future Incident Venous Thromboembolism.
    Frischmuth T; Hindberg K; Aukrust P; Ueland T; Brækkan SK; Hansen JB; Morelli VM
    Thromb Haemost; 2022 Apr; 122(4):560-569. PubMed ID: 34264516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of vitamin D are not associated with future risk of venous thromboembolism. The Tromsø Study.
    Brodin E; Lerstad G; Grimnes G; Brækkan SK; Vik A; Brox J; Svartberg J; Jorde R; Hansen JB
    Thromb Haemost; 2013 May; 109(5):885-90. PubMed ID: 23446951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observationally and Genetically High YKL-40 and Risk of Venous Thromboembolism in the General Population: Cohort and Mendelian Randomization Studies.
    Kjaergaard AD; Johansen JS; Bojesen SE; Nordestgaard BG
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):1030-6. PubMed ID: 26988593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated plasma concentration of complement factor C5 is associated with risk of future venous thromboembolism.
    Skjeflo EW; Brækkan SK; Ludviksen JK; Snir O; Hindberg K; Mollnes TE; Hansen JB
    Blood; 2021 Nov; 138(21):2129-2137. PubMed ID: 34339498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth Differentiation Factor-15, High-Sensitivity Cardiac Troponin T, and N-Terminal pro-B-type Natriuretic Peptide for Predicting Risk of Venous Thromboembolism in Ambulatory Cancer Patients Receiving Chemotherapy.
    Roy DC; Wang TF; Mallick R; Carrier M; Mollanji E; Liu P; Zhang L; Hawken S; Wells P
    Thromb Haemost; 2022 Jul; 122(7):1169-1176. PubMed ID: 35263789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Cytokines and Venous Thromboembolism: A Bidirectional Two-Sample Mendelian Randomization Study.
    Hu T; Su P; Yang F; Ying J; Chen Y; Cui H
    Thromb Haemost; 2024 May; 124(5):471-481. PubMed ID: 38109907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth differentiation factor-15 and prediction of cancer-associated thrombosis and mortality: a prospective cohort study.
    Nopp S; Moik F; Kraler S; Englisch C; Preusser M; von Eckardstein A; Pabinger I; Lüscher TF; Ay C
    J Thromb Haemost; 2023 Sep; 21(9):2461-2472. PubMed ID: 37192696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.